State Bank of India adopted its financial statements for the year ended March 31, 2026, at its 71st Annual General Meeting held on June 18, 2026. The resolution to adopt the Balance Sheet, Profit and Loss Account, and the Auditor's Report received 99.94% approval, with 159,415,103 votes cast in favour and 101,287 against. The meeting was conducted through video conferencing, chaired by Shri Challa Sreenivasulu Setty.

Remote e-voting was conducted from June 14, 2026, to June 17, 2026, via the National Securities Depository Limited (NSDL) platform. Shareholders holding shares in physical or dematerialized form as of the cut-off date of March 13, 2026, were entitled to vote. Mitesh Dhabliwala of Parikh & Associates, Practising Company Secretaries, served as the scrutiniser for the e-voting process.

The total number of valid votes polled was 159,516,390, representing 1.73% of the outstanding shares. Promoter and Promoter Group votes accounted for 101,595,505 votes, all cast in favour. Public-Institutions cast 57,902,183 votes, with 99.83% in favour, while Public-Non-Institutions cast 18,702 votes, with 98.90% in favour.

Voting Breakdown

The report of the scrutiniser will be submitted to the stock exchanges and made available on the Bank's official website and NSDL's website as per Regulation 44(3) of the SEBI (LODR) Regulations, 2015.

State Bank of India’s board has approved raising ₹60,000 crore through debt instruments during FY27 to bolster its capital base. The fund raising will be conducted via public offer or private placement targeting Indian and overseas investors, subject to government approval. This strategic move aims to manage the bank's capital requirements efficiently by issuing instruments in INR or foreign convertible currencies.

The approval includes the issuance of Long Term Bonds, Basel III compliant Additional Tier 1 Bonds, and Basel III compliant Tier 2 Bonds. The Central Board meeting, held under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, commenced at 10.00 am and concluded at 1.15 pm on June 18, 2026.

Fund Raising Details

The board outlined specific parameters for the capital infusion, providing flexibility in instrument selection and investor targeting.

The regulatory filing was submitted to the BSE Limited and National Stock Exchange of India Limited on June 18, 2026, by Aruna N. Dak, DGM (Compliance & Company Secretary).